Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bio-signatures of Pain and Anakinra Challenge
NCT05074485Phase 1Recruiting
- Start
- Jul 2021
- Primary completion
- May 2026
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of anakinra in pain. Primary endpoint: McGill Pain Questionnaire Total Pain Score. Started Jul 2021; status: recruiting.
02
Drugs
anakinra
03
Conditions
pain
Beyond the preview
Go deeper on NCT05074485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05074485.